Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.
The FTC has back-burnered its price collusion case against CVS Caremark, Optum Rx and Express Scripts after significant staff departures at the agency left it uncertain how to proceed.
The confirmation vote mostly fell on party lines. The Emmy-award-winning TV personality will replace Chiquita W. Brooks-LaSure, who has held the position since 2021.
"I feel very privileged to have led such an experienced and capable board of directors," the Radiology Business Management Association's 2024-2025 leader writes in a Radiology Business guest column.
The platform was designed to enhance the early detection of health conditions known to affect women in their 40s and older, including breast cancer, cardiovascular disease and osteoporosis.
Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.
Christopher M. Kramer, MD, is a longtime cardiologist and cardiac imaging specialist. His one-year term as the head of the American College of Cardiology officially began at the end of ACC.25 in Chicago.
Christopher M. Kramer, MD, is a longtime cardiologist and cardiac imaging specialist. His one-year term as the head of the American College of Cardiology officially began at the end of ACC.25 in Chicago.
Many if not most hospitals and other provider organizations take a decided interest in what their peer institutions are doing with AI. A major motivator for the keen curiosity is gauging how well one is keeping up with the Joneses. So to speak.
The FTC has back-burnered its price collusion case against CVS Caremark, Optum Rx and Express Scripts after significant staff departures at the agency left it uncertain how to proceed.
The confirmation vote mostly fell on party lines. The Emmy-award-winning TV personality will replace Chiquita W. Brooks-LaSure, who has held the position since 2021.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/stack_views/public/2024-09/istock-1209664264.jpg.webp?itok=MzQCOefT)
